CYTK Q2 2025 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M+26714.9% YoY

Gross Profit

$64M96.6% margin

Operating Income

-$112M-167.0% margin

Net Income

-$134M-201.2% margin

EPS (Diluted)

$-1.12

QoQ Revenue Growth

+4128.6%

Cash Flow

Operating Cash Flow

-$128M

Free Cash Flow

-$132M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$1.6B

Stockholders' Equity

-$369M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$249,000	+26714.9%
Gross Profit	$64M	-$79M	+181.3%
Operating Income	-$112M	-$130M	+14.3%
Net Income	-$134M	-$143M	+6.2%

Revenue Segments

Collaboration Revenues

$2M100%